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Abstract The effects of metal cations on the activation of
recombinant human SK4 (also known as hIK1 or hKCa4)
channels, expressed in HEK 293 cells, were tested using patch
clamp recording. Of the nine metals tested, cobalt, iron,
magnesium, and zinc did not activate the SK4 channels when
applied, at concentrations up to 100 WM, to the inside of SK4
channel-expressing membrane patches. Barium, cadmium, cal-
cium, lead, and strontium activated SK4 channels in a
concentration-dependent manner. The rank order of potency
was at Ca2+sPb2+sCd2+sSr2+sBa2+.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Small-conductance calcium-activated potassium channels
(SK channels) are expressed by neurons, smooth muscle, neu-
roendocrine cells, and hematopoietic cells [1^4]. SK channels
regulate neuronal electrical excitability and hormone secretion
from endocrine cells, and are involved in lymphocyte activa-
tion [3,5^7]. Recent cloning and functional expression of SK
channel genes has revealed that these channels belong to the
superfamily of ion channels which includes voltage-activated
K channels (typi¢ed by Shaker), calcium-activated large con-
ductance K channels (BK channels), and cyclic nucleotide
gated channels [3,8^12]. Moreover, SK channels have been
implicated in disorders such as schizophrenia, bipolar a¡ective
disorder [12,13], diamond blackfan anemia [14], and myotonic
muscular dystrophy [15].
The cloning and expression of recombinant SK channels
has shown that, although these channels are activated by
sub-micromolar concentrations of intracellular calcium, no
recognizable Ca2 binding motifs can be found in the channel
sequences [8,10]. Therefore, in the absence of amino acid se-
quence landmarks, understanding the underlying mechanisms
of SK channel activation must be preceded by structure-func-
tion studies. There is considerable literature on the interaction
of metal cations with calcium binding proteins including calm-
odulin, troponin, and the SK and BK channels. In previous
studies with native channels, the molecular identity of the
channels under study was uncertain. In this study, recombi-
nant human SK4 channels were used to explore the identity
and potency of activation by metal cations.
2. Materials and methods
2.1. Cells
The experiments were performed on a cell line derived from human
embryonic kidney ¢broblasts (HEK 293). These cells permanently
express recombinant hSK4 channels under the control of a cytome-
galovirus promoter, and are resistant to the antibiotic G418. The cell
lines were generated by transfecting the HEK 293 cells with a plasmid
construct encoding the hSK4 sequence and a neomycin resistance gene
contained within the mammalian expression vector pcDNA 3.0 (In-
vitrogen). G418-resistant colonies were clonally puri¢ed and tested for
hSK4 expression by patch clamp. The cells were grown in minimal
essential medium supplemented with Glutamax, penicillin/streptomy-
cin, sodium pyruvate and 1 mg/ml G418 (Life Technologies Inc.). The
cells were grown at 37‡C in a water-saturated 5% CO2, 95% air at-
mosphere, and passaged 1^2 times weekly. For recording the cells
were plated on 35 mm Falcon 3001 plastic Petri dishes 12^24 h prior
to recording.
2.2. Electrophysiology
Two variants of the inside-out patch clamp technique were used to
record recombinant hSK4 channels constitutively expressed in mem-
brane patches from HEK 293 cells. To determine single channel con-
ductance we used small-tipped pipettes (W30 M6 tip resistance),
made from thick-wall quartz capillaries for lower-noise recordings
[16]. For determination of potency of activation by metal cations
we used large-tipped, macropatch pipettes made from thin-walled
borosilicate glass (W3 M6 tip resistance), and coated with a hydro-
phobic polymer. Seal resistance was 30^100 G6 for the micropatches
and 10^30 G6 for the macropatches. A computer-controlled patch
clamp ampli¢er (EPC-9, HEKA [17]) was used to record the channels.
Data were sampled at 10 kHz and ¢ltered at 1 kHz (8 pole Bessel).
The software (Pulse 8.11, HEKA) controlled stimulation and data
acquisition. The data were analyzed o¥ine using Pulse software, as
well as TAC v. 3 (Bruxton Corp.). Single channel amplitudes were
then determined from Gaussian ¢ts to all-point amplitude histograms
from 1 min of recording at each membrane potential. For measuring
change in open probability (Po), the macropatch was held at
3100 mV, and cation solutions were applied for 30 s. The potency
of SK4 channel activation by metal cations was determined by calcu-
lating the electrical charge, i.e. integrating a 10-s segment of mem-
brane current during the cation response, subtracting the charge due
to holding current, and normalizing to the charge transduced by max-
imal activation by calcium, in the same patch. Solutions were applied
to the cytoplasmic aspect of the membrane patches using a 500 Wm
glass tube connected to a micro-manifold of 10 similar tubes. After
excision, the membrane patch was placed at the center of the £ow out
of this tube. A set of valves controlled which solution was £owing
through the tube and thus exposed to the patch at any given time. We
tested the speed of the perfusion system by monitoring the changes in
junction potential following the switch from Ringer to 10% Ringer.
The solution changed with a time constant of V1 s, achieving steady
state within 4^6 s after switching. The cytoplasmic aspect of the mem-
brane patches was constantly perfused with low calcium solution con-
taining 2 mM Mg2. All measurements were made at room temper-
ature (25‡C).
2.3. Solutions
The following metal salts were used: BaCl2, CaCl2, CdCl2, CoCl2,
FeCl2, Pb(NO3)2, SrCl2, and ZnCl2 (Fluka and Sigma Chemicals).
The maximal stated contamination of any metal salt by the other
metals was 0.05^0.06%. In view of the exquisite sensitivity of SK
channels to calcium we were particularly concerned about contami-
nation with this ion. Stock aqueous solutions of these salts were there-
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fore analyzed for calcium content by inductively coupled plasma
atomic emission spectrophotometry (ICP-AES) at Northwestern Uni-
versity Analytical Chemistry Facility. Calcium content ranged from
2.3U1035 to 8.5U1035 (0.0023^0.0085%), yielding a maximum calci-
um content contributed by the salt in a 100 WM solution of 8.5 nM,
which is s 10 times lower than required for minimal activation of
SK4 channels (data not shown). We therefore concluded that the
metal salts were not a signi¢cant source of calcium that would inter-
fere with our results. All our solutions were made using Milli-Q water
(Millipore). This water contains about 1.2 WM free calcium as deter-
mined by ICP-AES. We therefore estimated that, in the absence of a
chelator, our calcium contamination would be unacceptably high
(W1.2 WM).
We removed calcium contamination using either £uoride or EGTA
as described in [21]. Brie£y, for metals (Ba2, Mg2, and Sr2) that
bind EGTA with very low a⁄nity (W103 higher dissociation con-
stant), compared to calcium we included 1.59 mM EGTA in the
solution to bu¡er the calcium without appreciably a¡ecting the metal
concentration. For metals (Cd2, Fe2, Pb2, Co2, and Zn2) that
bind EGTA with high a⁄nity we replaced potassium aspartate with
£uoride as the main component of the intracellular solution; the £u-
oride salts of these metals are soluble up to 0.7 mM, while calcium
£uoride is insoluble. The dissociation constant for our batch of EGTA
and its purity were determined analytically according to [18]. Pub-
lished values [19] for stability constants were used for other metals.
Thus the metals were diluted from aqueous stocks into one of two
base intracellular solutions of the composition (in mM): KF, 160;
HEPES, 5; pH adjusted with KOH to 7.2, or K aspartate, 160;
HEPES, 5; EGTA, 1.59; pH adjusted with KOH to 7.2. Barium binds
EGTA very sparingly and has a soluble £uoride. We therefore used
this ion with either of our two base intracellular solutions with iden-
tical results. Using these procedures we estimated the maximal free
calcium content of our intracellular solutions to be 6 50 nM. This is
in agreement with our observations that neither base intracellular
solution (KF or K aspartate) activated SK4 channels (see Fig. 2A).
Our protocol involved exposing each patch to two intracellular
solutions: a ‘low’ calcium and a ‘high’ calcium solution. The low
calcium intracellular solution contained (in mM): potassium aspartate
160; MgCl2 2; EGTA 1.6; HEPES 5; pH adjusted to 7.2 with KOH.
This low calcium solution was calculated to have less than 1 nM free
calcium. The high calcium intracellular solution had the same compo-
sition as the low calcium solution but with the addition of 1.59 mM
CaCl2 ; this solution was calculated to contain s 10 WM free Ca2
ions. Every patch was exposed to these solutions multiple times during
the experiment (see Fig. 3A); in every case the SK4 channels behaved
as expected, i.e. no activation by low calcium, maximal activation by
high calcium, and no run-down.
As an additional precaution we regularly washed our perfusion
tubing (Te£on and quartz) with 10 mM EDTA- and Chelex-100-
treated Milli-Q water.
In addition to the fast perfusion for patches, the recording chamber
was constantly perfused with modi¢ed mammalian Ringer of compo-
sition (in mM): KCl, 147; CaCl2 2; MgCl2 1; glucose 5; NaHCO3 2;
HEPES 10 (pH adjusted with KOH to 7.2).
3. Results
3.1. Single channel properties of hSK4 channels
The hSK4 channels were activated by intracellular calcium
(Fig. 1A). The channel openings were only seen in patches
excised from hSK4-expressing cell lines. More than 80% of
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Fig. 1. Activation of recombinant hSK4 channels by intracellular
calcium. A: hSK4 channels activated by alternating applications of
low (6 1 nM) and high (s 10 WM) calcium solutions to an inside-
out membrane patch voltage clamped at 3100 mV. The patch con-
tained at least four channels. B: Current-voltage relation of single
hSK4 channels activated by high calcium internal solution. The
data were expressed as means þ S.D. (n = 3^6). The solid line is a
weighted least-squares ¢t of a third-order polynomial to the mean
values of single channel amplitudes. Note the pronounced inward
recti¢cation even though the patch was exposed to symmetrical
[K].
Fig. 2. Activation of hSK4 channels by divalent metal cations. A: The single channel openings induced by Ba2, Sr2, Cd2 and Pb2 at the
indicated concentration. Channel openings are shown as downward de£ections. The holding potential was 3100 mV. Note that the control so-
lution with either KF or EGTA failed to induce any channel openings, consistent with the estimation of calcium contamination. B: Single cur-
rent-voltage relations of hSK4 channel activation by divalent metal cations. Solid line has been transposed from Fig. 1B to illustrate the simi-
larity in conductance of SK4 channels activated by calcium or other metal cations.
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the patches contained SK4 channels (ns 16). In contrast,
these channels were never observed in patches from non-trans-
fected cells or cell lines expressing the related channel rSK2
(data not shown; ns 10). The unitary conductance was esti-
mated from linear ¢ts to channel amplitudes over the holding
potential 360 mV to 3140 mV. In seven patches the unitary
conductance was 33.1 þ 3.1 pS (S.D.; see Fig. 1B). The con-
ductance and the pronounced inward recti¢cation at positive
potentials are similar to properties observed in channels in
erythrocyte and lymphocyte membranes, as well as recombi-
nant hSK4 channels observed in other studies [2,20]. Taken
together, the results illustrated in Fig. 1 suggest that the chan-
nels observed were recombinant hSK4 channels.
3.2. Activation of hSK4 channels by metal cations
Pb2, Cd2, Sr2, and Ba2, in addition to Ca2, activated
recombinant hSK4 channels (Figs. 2 and 3). In order to de-
termine whether the channels activated by these metal cations
were the same as the hSK4 channels activated by calcium, we
compared the conductance of channels opened under di¡erent
metal treatments. Pb2, Cd2, and Sr2 were applied at 10
WM concentration while Ba2 was applied at 100 WM as it
did not activate hSK4 channels at 10 WM. The current
through open channels was recorded at di¡erent applied vol-
tages. We determined the single channels conductance under
di¡erent metal treatments from single channel current voltage
plots as done for Ca2 activation above (Fig. 2). The single
channel conductances of SK4 channels activated by metals
were 36.1 pS, 33.1, 35.1 pS, and 33.0 pS for barium, cadmium,
lead, and strontium, respectively. We conclude that the chan-
nels activated by these cations had identical unitary conduct-
ance to those activated by calcium.
3.3. Relative potency of hSK4 channel activation by metal
cations
Fig. 3 shows SK4 channel currents activated by increasing
concentrations of some metal cations. Co2, Fe2, and Zn2
at 1, 10, and 100 WM failed to activate hSK4 channels (n = 3^4
macropatches). Sr2 and Cd2 monotonically increased Po
with concentration, while activation by Pb2 decreased at
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Fig. 3. Concentration-dependent activation of hSK4 channels by metal cations. A: Representative traces recorded from di¡erent ion treatments
at the indicated concentrations. The patch was ¢rst perfused with low calcium solution containing 2 mM Mg2 before any treatment. The
treatments were done in the sequence of cation base solution (control), high calcium concentration, 1 WM metal, 10 WM metal, 100 WM metal
then returned to high calcium concentration. The background leak current was 33 to 310 pA. The holding potential was 3100 mV. SK cur-
rent is shown downward. B: Relationship between open probability (Po) and the applied ion concentration. Po was normalized to high Ca2
Ringer solution (s 10 WM) for each patch and then averaged for 3^5 patches.
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higher concentrations (Fig. 3). Ba2 was only seen to activate
SK4 channels weakly at the highest concentration tested (100
WM). The rank order of e¡ect at the concentration range of
1^100 WM was Ca2sPb2sCd2s Sr2sBa2.
4. Discussion
We show that micromolar concentrations of certain metal
cations can e¡ectively activate hSK4 channels. The e¡ective-
ness with which divalent cations activate SK channels was
measured as a normalized open probability, a fraction of
the open probability achieved with patch exposure to a
super-maximally activating Ca2 concentration (s 10 WM).
Mg2 failed to activate hSK4 channels as no channel openings
were observed either in 2 mM Mg2 contained in low calcium
intracellular solution or in 10 WM Mg2 contained in KF
solution. Our results con¢rm and extend previous work on
native calcium-activated potassium channels [20^24]. We
show for the ¢rst time that intracellular strontium can activate
SK channels.
There are several reasons for studying the e¡ects of metal
cations on recombinant hSK4 channels. First, from the rela-
tive potency series of SK4 channel activation by cations we
can make comparisons between di¡erent SK channel isoforms
which may show di¡erences in activation by cations even
though calcium activates the subtypes equally well. Second,
the relative potency can provide insights into the binding and
channel isomerization reactions that underlie the open chan-
nel probability. Thus, an ion activates the channel di¡erently
from calcium because such ion either binds di¡erently, or
following binding the channel gates di¡erently. In other
words, from the analysis of the channel gating by di¡erent
cations we can uncouple the binding from the isomerization
steps of channel opening [25]. Related to this is the possibility
that there may be two or more di¡erent types of calcium
binding sites within the channel that can be distinguished by
metal cations. Thus, in BK channels a second site can be
distinguished because it binds cadmium di¡erently [26]. Fur-
thermore, the relative potency series can be correlated with
analogous data obtained from metal binding to protein sites
with resolved three-dimensional structures; from such corre-
lation it may be possible to predict some aspects of the inter-
action between cations and their binding sites on the SK
channels [27]. Finally, actions of metal cations on SK chan-
nels may be related to the physiological and pathophysiolog-
ical e¡ects of these cations. It is likely that the hSK4 channel
studied here is the Gardos channel of red blood cells [9,11,28].
Metal cations have potent e¡ects on ion transport across red
blood cell membranes; for example, the Gardos channel has
been reported to be e¡ectively activated by Pb2 [29], in agree-
ment with our results. Lead and cadmium have been shown to
compete with calcium for binding sites on signaling and reg-
ulatory molecules including calmodulin, troponin C, protein
kinase C, and phosphodiesterase [30^33], and strontium can
substitute for calcium in triggering transmitter release [34].
Comparison to the better studied BK channels indicates that
cations activate BK channels with di¡erent orders of potency
in di¡erent tissues. For example, Pb2 is the most e¡ective ion
at activating BK channel from mouse neuroblastoma cells
[22^24], but is without e¡ect on skeletal muscle BK channels
[21].
It is possible that some of the toxic e¡ects of metal ions [35]
may turn out to be mediated through aberrant activation of
SK channels. Future studies will delineate the SK channel
domains involved in metal binding and activation, as well as
determine whether activation by these ions di¡ers amongst the
various SK channel isoforms.
After this paper was submitted a report appeared [36] de-
scribing a calcium sensing mechanism in SK channels by
means of tightly associated calmodulin. Our results comple-
ment this paper. An interesting point raised by our data is
that although ions which activate SK4 channels also activate
calmodulin [31,32], they do so at a di¡erent order of potency.
It is conceivable that the di¡erences are due to transduction
mechanisms downstream of calmodulin binding.
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